News & Analysis as of

Pharmaceutical Industry Red Notices

Estlund Law, P.A.

Switzerland: INTERPOL’s Operation Pangea XVI- INTERPOL’s Focus on Fraud (Part 3 of 3)

Estlund Law, P.A. on

The last post in this series explored the pattern of erectile dysfunction drugs being the most seized substance by INTERPOL along with the risks of corruption within the operation. Today’s post will explore the ways in which...more

Estlund Law, P.A.

Mozambique, Australia and Qatar: INTERPOL’s Operation Pangea XVI- Pharmaceuticals, Red Notices, and sex (Part 2 of 3)

Estlund Law, P.A. on

The last post in this series described INTERPOL’s Operation Pangea and how law enforcement from varying countries use INTERPOL’s tools to share information and do cross-border investigations.  Today’s post will discuss the...more

Hogan Lovells

Antitrust, Competition and Economic Regulation Quarterly Newsletter - Winter 2017

Hogan Lovells on

FTC takes another look at merger remedies - On 3 February 2017, the U.S. Federal Trade Commission (“FTC”) released its Merger Remedies Study, which analyzed the success of merger remedies imposed by the FTC from 2006 to...more

Akin Gump Strauss Hauer & Feld LLP

Red Notice Newsletter - August 2015

Welcome to the August 2015 edition of Red Notice, a publication of Akin Gump Strauss Hauer & Feld LLP. This month on the anticorruption front, the U.S. Department of Justice (DOJ) and the U.S. Securities and Exchange...more

Akin Gump Strauss Hauer & Feld LLP

Red Notice Newsletter - October 2014

Welcome to the October 2014 edition of Red Notice, a publication of Akin Gump Strauss Hauer & Feld LLP. - This month on the anticorruption front, a Texas company agrees to pay more than $5 million to settle allegations...more

Akin Gump Strauss Hauer & Feld LLP

Red Notice Newsleter

Welcome to the May 2014 edition of Red Notice, a publication of Akin Gump Strauss Hauer & Feld LLP. This month, on the anticorruption front, Avon Products, Inc. (“Avon”) agrees to pay USD $135 million to settle a...more

6 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide